This week’s roundup discusses the impact of hormonal contraception on mood and covers new data on the use of ADHD medications, antidepressants, and antipsychotics during pregnancy.
This week’s roundup discusses postpartum psychosis and provides reassuring data on the safety of medications during pregnancy, including acetominophen.
This week’s roundup discusses how the timing of parental depression affects offspring's risk of psychiatric illness and emerging data on opioids, MOUD, and child neurodevelopment—read more.
This week’s roundup discusses neurodevelopmental disorders in children exposed to antidepressants during pregnancy, spans perinatal sleep and and new insights on what causes perimenopausal mood disorders—read more.
This week’s roundup spans perinatal sleep and relapse risk, extended-release buprenorphine in pregnancy, and new insights on fathers’ mental health and menopause brain aging—read more.
Learn more about the impact of perinatal depression on child neurodevelopment, new rapid-acting treatments for PPD, and new data reshaping how we treat menopausal symptoms.
This week’s list spans antidepressant safety, benefits of psychotropic medication continuation on postpartum self-harm risk, anti-seizure medications and congenital malformations, and new approaches to PPD screening.
This week’s roundup covers prenatal SARS-CoV-2 exposure and child neurodevelopment, cannabis use in pregnancy and related risks, and estradiol-linked mood changes during menopause.
Every week we review the most recent publications in women’s mental health.
Every week we review the most recent publications in women’s mental health.
